ArticleFrontiers in immunology2022

Granzyme B in circulating CD8+ T cells as a biomarker of immunotherapy effectiveness and disability in neuromyelitis optica spectrum disorders.

Ziyan Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.